Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
This report offers an overview of the market trends, drivers, and barriers with respect to the USA Point of Care Molecular Diagnostics market. It also provides a detailed overview of the market of different regions across West USA, South USA, Middle West USA, Northeast USA. The report deeply analyzes type and application in the USA Point of Care Molecular Diagnostics market. Detailed analysis of key players, along with key growth strategies adopted by Point of Care Molecular Diagnostics industry, the PEST and SWOT analysis are also included. In short, the report will provide a comprehensive view of the industry's development and features.
By Player:
Meridian Bioscience Inc (US)
DxNA, LLC (US)
Mesa Biotech Inc (US)
Alere Inc (US)
By Type:
Assays and Kits
Instruments or Analyzers
Services and Software
By End-User:
Respiratory Diseases
Sexually Transmitted Diseases
Hospital-acquired Infection
Oncology
Hepatitis
Others
By Region:
-
West USA
-
South USA
-
Middle West USA
-
Northeast USA
TABLE OF CONTENT
1 Report Overview
-
1.1 Product Definition and Scope
-
1.2 PEST (Political, Economic, Social and Technological) Analysis of Point of Care Molecular Diagnostics Market
-
1.3 Market Segment by Type
-
1.3.1 USA Point of Care Molecular Diagnostics Market Size and Growth Rate of Assays and Kits from 2016 to 2027
-
1.3.2 USA Point of Care Molecular Diagnostics Market Size and Growth Rate of Instruments or Analyzers from 2016 to 2027
-
1.3.3 USA Point of Care Molecular Diagnostics Market Size and Growth Rate of Services and Software from 2016 to 2027
-
1.4 Market Segment by Application
-
1.4.1 USA Point of Care Molecular Diagnostics Market Size and Growth Rate of Respiratory Diseases from 2016 to 2027
-
1.4.2 USA Point of Care Molecular Diagnostics Market Size and Growth Rate of Sexually Transmitted Diseases from 2016 to 2027
-
1.4.3 USA Point of Care Molecular Diagnostics Market Size and Growth Rate of Hospital-acquired Infection from 2016 to 2027
-
1.4.4 USA Point of Care Molecular Diagnostics Market Size and Growth Rate of Oncology from 2016 to 2027
-
1.4.5 USA Point of Care Molecular Diagnostics Market Size and Growth Rate of Hepatitis from 2016 to 2027
-
1.4.6 USA Point of Care Molecular Diagnostics Market Size and Growth Rate of Others from 2016 to 2027
-
1.5 Market Segment by Regions
-
1.5.1 West USA Point of Care Molecular Diagnostics Consumption Market Size and Growth Rate from 2016 to 2027
-
1.5.2 South USA Point of Care Molecular Diagnostics Consumption Market Size and Growth Rate from 2016 to 2027
-
1.5.3 Middle West USA Point of Care Molecular Diagnostics Consumption Market Size and Growth Rate from 2016 to 2027
-
1.5.4 Northeast USA Point of Care Molecular Diagnostics Consumption Market Size and Growth Rate from 2016 to 2027
2 Market Trends and Competitive Landscape
-
2.1 Market Trends and Dynamics
-
2.1.1 Market Challenges and Restraints
-
2.1.2 Market Opportunities and Potentials
-
2.1.3 Mergers and Acquisitions
-
2.2 Competitive Landscape Analysis
-
2.2.1 Industrial Concentration Analysis
-
2.2.2 Porter's Five Forces Analysis of the Industry
-
2.2.3 SWOT Analysis for New Entrants
-
2.3 Coronavirus (COVID-19) Distribution and its Impact on the Industry
3 Segmentation of Point of Care Molecular Diagnostics Market by Types
-
3.1 Products Development Trends of Different Types
-
3.2 Products Types of Major Vendors
-
3.3 Competitive Landscape Analysis of Different Types
-
3.4 Market Size of Point of Care Molecular Diagnostics by Major Types
-
3.4.1 Market Size and Growth Rate of Assays and Kits
-
3.4.2 Market Size and Growth Rate of Instruments or Analyzers
-
3.4.3 Market Size and Growth Rate of Services and Software
4 Segmentation of Point of Care Molecular Diagnostics Market by End-Users
-
4.1 Downstream Client Analysis by End-Users
-
4.2 Competitive Landscape Analysis of Different End-Users
-
4.3 Market Potential Analysis of Different End-Users
-
4.4 Market Size of Point of Care Molecular Diagnostics by Major End-Users
-
4.4.1 Market Size and Growth Rate of Point of Care Molecular Diagnostics in Respiratory Diseases
-
4.4.2 Market Size and Growth Rate of Point of Care Molecular Diagnostics in Sexually Transmitted Diseases
-
4.4.3 Market Size and Growth Rate of Point of Care Molecular Diagnostics in Hospital-acquired Infection
-
4.4.4 Market Size and Growth Rate of Point of Care Molecular Diagnostics in Oncology
-
4.4.5 Market Size and Growth Rate of Point of Care Molecular Diagnostics in Hepatitis
-
4.4.6 Market Size and Growth Rate of Point of Care Molecular Diagnostics in Others
5 Market Analysis by Regions
-
5.1 USA Point of Care Molecular Diagnostics Production Analysis by Regions
-
5.2 USA Point of Care Molecular Diagnostics Consumption Analysis by Regions
-
5.3 Coronavirus (COVID-19) Impact on USA Economy
6 West USA Point of Care Molecular Diagnostics Landscape Analysis
-
6.1 West USA Point of Care Molecular Diagnostics Landscape Analysis by Major Types
-
6.2 West USA Point of Care Molecular Diagnostics Landscape Analysis by Major End-Users
7 South USA Point of Care Molecular Diagnostics Landscape Analysis
-
7.1 South USA Point of Care Molecular Diagnostics Landscape Analysis by Major Types
-
7.2 South USA Point of Care Molecular Diagnostics Landscape Analysis by Major End-Users
8 Middle West USA Point of Care Molecular Diagnostics Landscape Analysis
-
8.1 Middle West USA Point of Care Molecular Diagnostics Landscape Analysis by Major Types
-
8.2 Middle West USA Point of Care Molecular Diagnostics Landscape Analysis by Major End-Users
9 Northeast USA Point of Care Molecular Diagnostics Landscape Analysis
-
9.1 Northeast USA Point of Care Molecular Diagnostics Landscape Analysis by Major Types
-
9.2 Northeast USA Point of Care Molecular Diagnostics Landscape Analysis by Major End-Users
10 Major Players Profiles
-
10.1 Meridian Bioscience Inc (US)
-
10.1.1 Meridian Bioscience Inc (US) Company Profile and Recent Development
-
10.1.2 Market Performance
-
10.1.3 Product and Service Introduction
-
10.2 DxNA, LLC (US)
-
10.2.1 DxNA, LLC (US) Company Profile and Recent Development
-
10.2.2 Market Performance
-
10.2.3 Product and Service Introduction
-
10.3 Mesa Biotech Inc (US)
-
10.3.1 Mesa Biotech Inc (US) Company Profile and Recent Development
-
10.3.2 Market Performance
-
10.3.3 Product and Service Introduction
-
10.4 Alere Inc (US)
-
10.4.1 Alere Inc (US) Company Profile and Recent Development
-
10.4.2 Market Performance
-
10.4.3 Product and Service Introduction
The List of Tables and Figures
-
Figure Product Picture
-
Figure USA Point of Care Molecular Diagnostics Market Size and Growth Rate of Assays and Kits from 2016 to 2027
-
Figure USA Point of Care Molecular Diagnostics Market Size and Growth Rate of Instruments or Analyzers from 2016 to 2027
-
Figure USA Point of Care Molecular Diagnostics Market Size and Growth Rate of Services and Software from 2016 to 2027
-
Figure Market Share by Type in 2016
-
Figure Market Share by Type in 2020
-
Figure Market Share by Type in 2027
-
Figure USA Point of Care Molecular Diagnostics Market Size and Growth Rate of Respiratory Diseases from 2016 to 2027
-
Figure USA Point of Care Molecular Diagnostics Market Size and Growth Rate of Sexually Transmitted Diseases from 2016 to 2027
-
Figure USA Point of Care Molecular Diagnostics Market Size and Growth Rate of Hospital-acquired Infection from 2016 to 2027
-
Figure USA Point of Care Molecular Diagnostics Market Size and Growth Rate of Oncology from 2016 to 2027
-
Figure USA Point of Care Molecular Diagnostics Market Size and Growth Rate of Hepatitis from 2016 to 2027
-
Figure USA Point of Care Molecular Diagnostics Market Size and Growth Rate of Others from 2016 to 2027
-
Figure Market Share by End-User in 2016
-
Figure Market Share by End-User in 2020
-
Figure Market Share by End-User in 2027
-
Figure West USA Point of Care Molecular Diagnostics Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure South USA Point of Care Molecular Diagnostics Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure Middle West USA Point of Care Molecular Diagnostics Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure Northeast USA Point of Care Molecular Diagnostics Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure Development Trends and Industry Dynamics of Point of Care Molecular Diagnostics Industry
-
Figure Market Challenges and Restraints
-
Figure Market Opportunities and Potentials
-
Table Mergers and Acquisition
-
Figure Market Share of TOP 3 Players in 2019
-
Figure Market Share of TOP 5 Players in 2019
-
Figure Market Share of TOP 6 Players from 2016 to 2020
-
Figure Porter's Five Forces Analysis
-
Figure New Entrant SWOT Analysis
-
Figure Coronavirus (COVID-19) Distribution Map of USA
-
Table Coronavirus (COVID-19) Impact on the Industry
-
Figure Specifications of Different Types of Point of Care Molecular Diagnostics
-
Figure Development Trends of Different Types
-
Table Products Types of Major Vendors
-
Figure Competitive Landscape Analysis of Different Types
-
Table Consumption of Point of Care Molecular Diagnostics by Different Types from 2016 to 2027
-
Table Consumption Share of Point of Care Molecular Diagnostics by Different Types from 2016 to 2027
-
Figure Market Size and Growth Rate of Assays and Kits
-
Figure Market Size and Growth Rate of Instruments or Analyzers
-
Figure Market Size and Growth Rate of Services and Software
-
Table Downstream Client Analysis by End-Users
-
Figure Competitive Landscape Analysis of Different End-Users
-
Table Market Potential Analysis of Different End-Users
-
Figure Consumption of Point of Care Molecular Diagnostics by Different End-Users from 2016 to 2027
-
Table Consumption Share of Point of Care Molecular Diagnostics by Different End-Users from 2016 to 2027
-
Figure Market Size and Growth Rate of Respiratory Diseases
-
Figure Market Size and Growth Rate of Sexually Transmitted Diseases
-
Figure Market Size and Growth Rate of Hospital-acquired Infection
-
Figure Market Size and Growth Rate of Oncology
-
Figure Market Size and Growth Rate of Hepatitis
-
Figure Market Size and Growth Rate of Others
-
Table USA Point of Care Molecular Diagnostics Production by Regions
-
Table USA Point of Care Molecular Diagnostics Production Share by Regions
-
Figure USA Point of Care Molecular Diagnostics Production Share by Regions in 2016
-
Figure USA Point of Care Molecular Diagnostics Production Share by Regions in 2021
-
Figure USA Point of Care Molecular Diagnostics Production Share by Regions in 2027
-
Table USA Point of Care Molecular Diagnostics Consumption by Regions
-
Table USA Point of Care Molecular Diagnostics Consumption Share by Regions
-
Figure USA Point of Care Molecular Diagnostics Consumption Share by Regions in 2016
-
Figure USA Point of Care Molecular Diagnostics Consumption Share by Regions in 2021
-
Figure USA Point of Care Molecular Diagnostics Consumption Share by Regions in 2027
-
Table West USA Point of Care Molecular Diagnostics Consumption by Types from 2016 to 2027
-
Table West USA Point of Care Molecular Diagnostics Consumption Share by Types from 2016 to 2027
-
Figure West USA Point of Care Molecular Diagnostics Consumption Share by Types in 2016
-
Figure West USA Point of Care Molecular Diagnostics Consumption Share by Types in 2021
-
Figure West USA Point of Care Molecular Diagnostics Consumption Share by Types in 2027
-
Table West USA Point of Care Molecular Diagnostics Consumption by End-Users from 2016 to 2027
-
Table West USA Point of Care Molecular Diagnostics Consumption Share by End-Users from 2016 to 2027
-
Figure West USA Point of Care Molecular Diagnostics Consumption Share by End-Users in 2016
-
Figure West USA Point of Care Molecular Diagnostics Consumption Share by End-Users in 2021
-
Figure West USA Point of Care Molecular Diagnostics Consumption Share by End-Users in 2027
-
Table South USA Point of Care Molecular Diagnostics Consumption by Types from 2016 to 2027
-
Table South USA Point of Care Molecular Diagnostics Consumption Share by Types from 2016 to 2027
-
Figure South USA Point of Care Molecular Diagnostics Consumption Share by Types in 2016
-
Figure South USA Point of Care Molecular Diagnostics Consumption Share by Types in 2021
-
Figure South USA Point of Care Molecular Diagnostics Consumption Share by Types in 2027
-
Table South USA Point of Care Molecular Diagnostics Consumption by End-Users from 2016 to 2027
-
Table South USA Point of Care Molecular Diagnostics Consumption Share by End-Users from 2016 to 2027
-
Figure South USA Point of Care Molecular Diagnostics Consumption Share by End-Users in 2016
-
Figure South USA Point of Care Molecular Diagnostics Consumption Share by End-Users in 2021
-
Figure South USA Point of Care Molecular Diagnostics Consumption Share by End-Users in 2027
-
Table Middle West USA Point of Care Molecular Diagnostics Consumption by Types from 2016 to 2027
-
Table Middle West USA Point of Care Molecular Diagnostics Consumption Share by Types from 2016 to 2027
-
Figure Middle West USA Point of Care Molecular Diagnostics Consumption Share by Types in 2016
-
Figure Middle West USA Point of Care Molecular Diagnostics Consumption Share by Types in 2021
-
Figure Middle West USA Point of Care Molecular Diagnostics Consumption Share by Types in 2027
-
Table Middle West USA Point of Care Molecular Diagnostics Consumption by End-Users from 2016 to 2027
-
Table Middle West USA Point of Care Molecular Diagnostics Consumption Share by End-Users from 2016 to 2027
-
Figure Middle West USA Point of Care Molecular Diagnostics Consumption Share by End-Users in 2016
-
Figure Middle West USA Point of Care Molecular Diagnostics Consumption Share by End-Users in 2021
-
Figure Middle West USA Point of Care Molecular Diagnostics Consumption Share by End-Users in 2027
-
Table Northeast USA Point of Care Molecular Diagnostics Consumption by Types from 2016 to 2027
-
Table Northeast USA Point of Care Molecular Diagnostics Consumption Share by Types from 2016 to 2027
-
Figure Northeast USA Point of Care Molecular Diagnostics Consumption Share by Types in 2016
-
Figure Northeast USA Point of Care Molecular Diagnostics Consumption Share by Types in 2021
-
Figure Northeast USA Point of Care Molecular Diagnostics Consumption Share by Types in 2027
-
Table Northeast USA Point of Care Molecular Diagnostics Consumption by End-Users from 2016 to 2027
-
Table Northeast USA Point of Care Molecular Diagnostics Consumption Share by End-Users from 2016 to 2027
-
Figure Northeast USA Point of Care Molecular Diagnostics Consumption Share by End-Users in 2016
-
Figure Northeast USA Point of Care Molecular Diagnostics Consumption Share by End-Users in 2021
-
Figure Northeast USA Point of Care Molecular Diagnostics Consumption Share by End-Users in 2027
-
Table Company Profile and Development Status of Meridian Bioscience Inc (US)
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Meridian Bioscience Inc (US)
-
Figure Sales and Growth Rate Analysis of Meridian Bioscience Inc (US)
-
Figure Revenue and Market Share Analysis of Meridian Bioscience Inc (US)
-
Table Product and Service Introduction of Meridian Bioscience Inc (US)
-
Table Company Profile and Development Status of DxNA, LLC (US)
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of DxNA, LLC (US)
-
Figure Sales and Growth Rate Analysis of DxNA, LLC (US)
-
Figure Revenue and Market Share Analysis of DxNA, LLC (US)
-
Table Product and Service Introduction of DxNA, LLC (US)
-
Table Company Profile and Development Status of Mesa Biotech Inc (US)
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Mesa Biotech Inc (US)
-
Figure Sales and Growth Rate Analysis of Mesa Biotech Inc (US)
-
Figure Revenue and Market Share Analysis of Mesa Biotech Inc (US)
-
Table Product and Service Introduction of Mesa Biotech Inc (US)
-
Table Company Profile and Development Status of Alere Inc (US)
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Alere Inc (US)
-
Figure Sales and Growth Rate Analysis of Alere Inc (US)
-
Figure Revenue and Market Share Analysis of Alere Inc (US)
-
Table Product and Service Introduction of Alere Inc (US)
-
